Japan
Ageing population, tech drive Japan’s medical device market
The country is already home to the highest senior population ratio in the world.
Japanese pharma company buys US drugmaker for $5.9b
The US firm is developing a treatment for one the major causes of vision loss in aging adults.
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
embecta Japan wins award for mobile app that supports diabetes patients between doctor visits
A free educational and lifestyle tool designed to help people with diabetes.Â
Japan’s over-the-counter drugs sector in the doldrums
An elevated demand for prescription drugs has held back demand for OTC drugs.
How Japan’s pharma companies gain value from real-world evidence
The world's top 20 pharma firms can gain $300m a year using advanced analytics.
Japan tops global survey for most number of hospitals
 Thirty-three of the most developed countries were part of the survey.
Asahi Intecc wins at Healthcare Asia Medtech Awards 2022
The company is leading the way in guidewire for minimally invasive treatments.
Bristol-Myers Squibb Japan wins Digital Innovation of the Year
It was awarded for its PSP@SNS Platform at the Healthcare Asia Pharma Awards.
Nipro Corporation wins a Healthcare Asia Medtech Award
The company’s aerosol disinfectant is revolutionising airborne infection control in hospitals and other indoor spaces.
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.
NDR Medical expands with new Japan office
It marked the fourth location in the Asia Pacific.
Japanese teenager first to use hospital's 'confidential birth'
The system was the only one of its kind in the country.
Slowing economy to affect Japan’s pharmaceuticals spending: Fitch
It also said that the annual medicine price review will affect medicine’s market growth trajectory.Â
Disease awareness boosts Japan’s KRAS oncogene test market
Nucleic acid amplification tests dominate the market.
Drug approvals boost Japanese migraine treatment online
Some players have been highly active in digital channels of various countries.
Resource Center
Read Here
Advertise
Sign Up
Event News
Event News
Malaysia's first one stop rehabilitation centre
![Malaysia's first one stop rehabilitation centre]()
Co-Written / Partner
WQ Park is a Specialised Health and Rehabilitation Centre providing comprehensive treatment for patients of all ages – from infant to elderly.
WQ Park is a Specialised Health and Rehabilitation Centre providing comprehensive treatment for patients of all ages – from infant to elderly.
